Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine
December 29 2021 - 8:00AM
Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a
pharmaceutical producer and distributor in China, today announced
that the Company had entered into a strategic cooperation agreement
(the “Agreement”) with Jinggangshan University (“JGSU”), a public
university located in Ji'an City of Jiangxi Province, for a study
on the chemical constituents of Liparis Odorata, a traditional
Chinese medicine, for the treatment of hyperlipidemia.
Under the Agreement, JGSU agrees to conduct the
aforementioned studies and provide scientific research results to
the Company, and report to the Company upon completion within 24
months from the date of the Agreement.
Mr. Gang Lai, Chairman and CEO of Universe
Pharmaceuticals INC, commented, “We are excited to collaborate with
JGSU on this research partnership since JGSU has an impressive
track record of cutting-edge research in studies of Chinese
medicines, and its expertise and resources will be invaluable to
us. It is critical that pharmaceutical companies and academic
institutions work together to develop Chinese medicine for diseases
with significant unmet market and medical needs, and JGSU is one of
the ideal partners to support us in this effort. Working with JGSU,
we expect to be at the forefront of developing Chinese medicines
with better efficacy and market recognition.”
About
Jinggangshan University
Established in 1958 and located in the
Jinggangshan Mountains in Qingyuan District, Ji'an city of Jiangxi
province in China, JGSU is jointly supported by the Ministry of
Education of the People's Republic of China and the People's
Government of Jiangxi Province and pair-assisted by Tongji
University. In July 2003, approved by the Ministry of Education of
the People’s Republic of China, Jinggangshan Normal University was
renamed to Jinggangshan University by joining Jinggangshan Medicine
College and Jinggangshan Vocational Technical College. The Medical
School of Jinggangshan University possesses a Level 3A graded
affiliated hospital, the Jinggangshan University Affiliated
Hospital, which consists of 35 medical departments and sections and
is listed in World Health Organization, Foundation for Advancement
of International Medical Education and Research (FAIMER), the
Geneva Foundation for Medical Education and Research (GFMER), as
well as the AVICENNA Directory for medicine. For more information,
visit the company’s website at http://www.jgsu.edu.cn/.
About Universe Pharmaceuticals
INC
Universe Pharmaceuticals INC, headquartered in
Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor
in China. The Company specializes in the manufacturing, marketing,
sales and distribution of traditional Chinese medicine derivatives
products targeting the elderly with the goal of addressing their
physical conditions in the aging process and to promote their
general well-being. The Company also distributes and sells
biomedical drugs, medical instruments, Traditional Chinese Medicine
Pieces, and dietary supplements manufactured by third-party
pharmaceutical companies. Currently, the Company’s products are
sold in 30 provinces of China. For more information, visit the
company’s website at http://www.universe-pharmacy.com/.
Forward-Looking Statements
All statements other than statements of
historical fact in this announcement are forward-looking
statements. These forward-looking statements involve known and
unknown risks and uncertainties and are based on current
expectations and projections about future events and financial
trends that the Company believes may affect its financial
condition, results of operations, business strategy and financial
needs. Investors can identify these forward-looking statements by
words or phrases such as "may," "will," "expect," "anticipate,"
"aim," "estimate," "intend," "plan," "believe," "potential,"
"continue," "is/are likely to" or other similar expressions. The
Company undertakes no obligation to update forward-looking
statements to reflect subsequent occurring events or circumstances,
or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in
these forward-looking statements are reasonable, it cannot assure
you that such expectations will turn out to be correct, and the
Company cautions investors that actual results may differ
materially from the anticipated results and encourages
investors to review other factors that may affect its future
results in the Company’s registration statement and in its other
filings with the SEC.
For more information, please
contact:
Ascent Investors Relations
LLCTina XiaoPresidentPhone:
917-609-0333Email: tina.xiao@ascent-ir.com
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Jul 2023 to Jul 2024